PEPGEN INC. Share | Buy US Stock from India on Kuvera

Q: Can I buy PEPGEN INC. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell PEPGEN INC. stocks after a simple registration process. </div>

Q: How to buy PEPGEN INC. shares in India?

<div> To buy PEPGEN INC. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for PEPGEN INC. and you are done!</div> </div>

Q: What is the share price of PEPGEN INC.?

<div>The share price of PEPGEN INC. is USD 14.49 as on 2 May.</div>

Q: What is the Market Capitalization of PEPGEN INC.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of PEPGEN INC. is USD 469.34M as on 2 May.</div>

Q: What is the PE ratio of PEPGEN INC.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of PEPGEN INC. is N/A as on 2 May. </div>

Q: Is PEPGEN INC. a good stock to buy?

<div>Kuvera provides relevant fundamental details of PEPGEN INC. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does PEPGEN INC. operate?

<div> PEPGEN INC. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$14.49

+0.59

(2 May)

Loading Chart

Previous close

$14.49

Open

$14.49

Today’s high

$14.59

Today’s low

$13.41

52W low

$3.72

52W high

$17.51

1.68%

Shares O/S

32.39M

Market cap

469.34M

Insights

No insights found for this stock

Compare with other stock

About PEPGEN INC.

PepGen Inc. is a clinical-stage biotechnology company. The Company is engaged in advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. Its proprietary enhanced delivery oligonucleotide (EDO), platform leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics.

Its EDO peptides are engineered to optimize tissue penetration, cellular uptake and nuclear delivery. Using these EDO peptides, the Company is generating a pipeline of oligonucleotide therapeutic candidates that are designed to target the root cause of serious diseases. The Company’s pipeline consists of two clinical stage programs: PGN-EDO51 for duchenne muscular dystrophy (DMD) patients who are amenable to exon 51-skipping and PGN-EDODM1 for myotonic dystrophy type 1 (DM1) patients. It also has three additional preclinical stage programs: PGN-EDO53, PGN-EDO45 and PGN-EDO44. .

FAQs

Can I buy PEPGEN INC. shares in India?

How to buy PEPGEN INC. shares in India?

What is the share price of PEPGEN INC.?

What is the Market Capitalization of PEPGEN INC.?

What is the PE ratio of PEPGEN INC.?

Is PEPGEN INC. a good stock to buy?

In which sector / industry does PEPGEN INC. operate?